Is a complete ACIU research report available?

No complete published report is available for AC Immune SA (ACIU) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AC Immune SA (ACIU)

NASDAQ: ACIU · USD

$2.37

+0.10 (+4.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ACIU analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	235.1M
Revenue (ttm)	4.6M
Net income (ttm)	-82.6M
EPS (ttm)	-$0.82
Shares out	99.2M
Volume	245,774
Beta	1.57
Price target	$8.52	+259.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.6M
Net income (ttm): -82.6M
EPS (ttm): -$0.82
Market cap: 235.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ACIU indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

CHF

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001651625
Company name	AC Immune SA
Country	Switzerland
Country code	US
Cusip	H00263105
Employees	122
Employees Change	-50%
Employees Change Percent	-29.07
Enterprise value	$143.3M
Exchange	NASDAQ
Financial currency	CHF
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-09-23
Isin	CH0329023102
Last refreshed	2026-07-31
Market cap	$235.1M
Market cap category	Micro-Cap
Price	$2.37
Price currency	USD
Rev Per Employee	37,830.08x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	ACIU
Website	https://www.acimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.72%
EV Sales Forward	4.07x
EV/Sales	31.04x
FCF yield	-37.76%
P/B ratio	5.7x
P/S ratio	50.08x
PS Forward	6.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,742.44%
EBITDA Margin	-1,742.44%
Gross Profit	$-60.5M
Net Income	$-82.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1,788.74%
Profit Per Employee	$-676,680
ROA	-23.06
Roa5y	-19.18
ROCE	-142.5
ROE	-104.8
Roe5y	-45.56
ROIC	-59.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.85%
Cagr3y	-6.5%
Cagr5y	-19.73%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-86.92x
Revenue Growth Q	13.03x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.01x
Revenue Growth5 Y	3.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$171.3M
Cash	$93.2M
Current Assets	$99.6M
Current Liabilities	$114.8M
Debt	$5.4M
Debt Equity	$0.14
Equity	$39.3M
Interest Coverage	-318.6
Liabilities	$132M
Long Term Assets	$71.7M
Long Term Liabilities	$17.3M
Net Cash	$87.9M
Net Cash By Market Cap	$38.02
Net Cash Growth	-49.81%
Net Debt Equity	$-2.24
Tangible Book Value	$-23.5M
Tangible Book Value Per Share	$-0.24
WACC	12.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Net Working Capital	$-107.4M
Quick ratio	0.83
Working Capital	$-15.2M
Working Capital Turnover	$0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.43%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.85%
200-day SMA	2.92
3Y total return	-18.28%
50-day SMA	2.45
50-day SMA vs 200-day SMA	50under200
5Y total return	-66.67%
All Time High	19.97
All Time High Change	-88.13%
All Time High Date	2016-09-28
All Time Low	1.43
All Time Low Change	65.73%
All Time Low Date	2025-04-09
ATR	0.13
Beta	1.57
Beta1y	1.12
Beta2y	1.38
Ch YTD	-24.52
High	2.41
High52	4
High52 Date	2025-10-29
High52ch	-40.75%
Low	2.25
Low52	2.03
Low52 Date	2025-08-29
Low52ch	16.75%
Ma50ch	-3.11%
Premarket Change Percent	3.08
Premarket Price	$2.34
Premarket Volume	142
Price vs 200-day SMA	-18.81%
RSI	50.1
RSI Monthly	44.84
RSI Weekly	43.66
Sharpe ratio	0.34x
Sortino ratio	0.61
Total Return	-0.43%
Tr YTD	-24.52
Tr1m	-10.9%
Tr1w	5.8%
Tr3m	-19.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.22
Earnings Revenue Estimate	1,000,000x
Earnings Revenue Estimate Growth	-35.02x
Operating Income	$-80.1M
Operating margin	-1,736.4
Price target	$8.52
Price Target Change	$259
Price Target Change Top	$322

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,959,699%
Float Percent	39.27%
Net Borrowing	-1,276,278.1
Shares Insiders	5.72%
Shares Institutions	5.48%
Shares Out	99,201,152
Shares Qo Q	-2.37%
Shares Yo Y	0.43%
Short Ratio	13.25
Short Shares	6.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-92.7M
Adjusted OCF	-91,625,824.1
Average Volume	202,404.55x
Bv Per Share	0.4
CAPEX	$-1.1M
Ch1m	-10.9
Ch1w	5.8
Ch1y	0.85
Ch3m	-19.11
Ch3y	-18.28
Ch5y	-66.67
Ch6m	-30.29
Change	4.41%
Change From Open	3.04
Close	2.27
Days Gap	1.32
Depreciation Amortization	1,716,942.4
Dollar Volume	582,484.4
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-80.2M
EBITDA	$-80.2M
EPS	$-0.82
F Score	0
FCF	$-87.3M
FCF EV Yield	-60.92x
FCF Per Share	$-0.88
Financing CF	-1,268,814.5
Fiscal Year End	December
Founded	2,003
Investing CF	79,042,169.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	2.86
Ma150ch	-17.07%
Ma20	2.36
Ma20ch	0.38%
Net CF	-11,792,511.5
Next Earnings Date	2026-08-11
Open	2.3
Optionable	Yes
Position In Range	77.42
Post Close	2.37
Postmarket Change Percent	-0.42
Postmarket Price	$2.36
Ppne	7,920,139.3
Pre Close	2.27
Price Date	2026-07-30
Relative Volume	1.21x
Revenue	4,615,270x
SBC By Revenue	123.03x
Share Based Comp	5,468,341.8
Tr6m	-30.29%
Volume	245,774
Z Score	-5.09

AC Immune SA (ACIU)

Coverage state: Market snapshot only — no published research

Generate the first ACIU analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACIU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACIU indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACIU

Frequently asked questions